- Iranians holding Ashura mourning for Imam Hussein
- Third step: Iran officially informs EU of plan to expand nuclear R&D
- Iran expands nuclear R&D program: Rouhani
- Iran goes ahead in space tech, despite US sanctions: ISA
- Resistance Front undermining Israeli regime power: Top commander
- Iran: 7 crew members of detained UK ship freed
- US addiction to sanction threaten its power: Iran’s Zarif
- Dutch role in 2007 Stuxnet attack on Iran’s nuclear site under scrutiny: Iraian FM Spox.
- Iran: ‘Sustainable Security 2019’ kicks off in Caspian Sea
- Iran’s Zarif leaves Tehran for Moscow
- Shiraz University ranked 1st in liver transplantation: Iranian health official
- Japan’s Abe to meet Iran’s president to discuss easing tension in region
- Downing of US spy drone shattered war threats against Iran: Top IRGC commander
- IAEO head reports development of first ion-therapy hospital in west of Asia
- Iranian Taekwondo team wins 2019 World Cup championship
- US sanctions failed to force Iran to buckle: Report
- Crew fixing Iran oil tanker broken down in Red Sea
- As Iranians hold nerves, US seeks to scare off trade
- Leader expresses concern about Kashmir, urges India to follow fair policy toward Muslim-majority region
- Iran saffron exports down due to smuggling, government restrictions: Exporter
- Iran FM warns US against ‘serious miscalculation’ in Persian Gulf
- Iran’s resistance policy led to release of oil tanker: MP
- Iran in reverse brain drain as top students come home in rising numbers
- Iran official calls for compensation for tanker seizure
- Iran hails N Korea for standing against ‘unilateral’ US demands
- Shia Muslims celebrate Eid Al-Ghadir
- North Korea praises Iran’s anti-US struggle
- Zarif says to meet French president Friday
- Iranian court hearing case of UK oil tanker
- Over half of Japanese voters oppose joining US-led anti-Iran coalition in Persian Gulf: Poll
- IME trade ups by 21 percent in July
- Finland backs INSTEX in defiance of US
- US anti-Iran policy in high seas harms Europeans: LA Times
- Iran, China confer on Syria
- Iran, Finland share views on Persian Gulf dialogue forum: Zarif
- Iran warns US against seizure of oil tanker
- Iraq eager to benefit from Iranian Police’s experience
- Iran planning 3rd step to reduce nuclear commitments: Spokesman
- Leader grants clemency to over 1,000 Iranian inmates
- Registration for Arbaeen Pilgrimage to begin in Iran on Friday
- Iran, Iraq agree to reopen Khosravi border crossing
- Iran deplores suicide attack at Kabul wedding hall
- Iran to hold int'l hand-woven carpets expo
- Zarif meets with Iran-Kuwait Friendship Group members
- Adrian Darya oil tanker not under any sanctions, says Iran envoy
- ‘Iran to stay in nuclear deal as long as its interests are met’
- India envoy happy with positive trend of trade with Iran
- Iran’s annual export of white meat tops 2.5m tons: Minister
- Iranian scientist discovers new state of matter
- Iran, Japan diplomats discuss bilateral ties
- Iran, Ansarullah, European representatives Yemen developments
- ‘Iran to become self-sufficient in producing aircraft engines'
- US issues seizure warrant for Iranian supertanker 'Grace 1'
- Neanderthal tooth unearthed near Iran’s Zagros mountain
- Iran’s Zarif due in Kuwait on Saturday
- US faces humiliating defeat after Gibraltar releases Iranian tanker: Envoy
- Spokesman rejects claim on Iran’s commitment in exchange for tanker release
- Zarif reacts to release of Iranian tanker in Gibraltar
- Israel, UAE engaged in secret talks on Iran arranged by US: Report
- US threatens visa ban as Iranian-operated tanker sets to sail from Gibraltar
- Enemies must factor Iran's global power in their calculations: IRGC's chief commander
- Trump’s administration conflicting messages to Iran baffle go-betweens: Report
- Gibraltar releases Iran-operated tanker despite US pressure
Monday, 22 February 2021_Iran’s COVIran Barekat, the first domestically-developed COVID-19 vaccine in the country, has showed 90-percent effectiveness, according the first phase of human trials of the inoculation.
Mohamad Reza Salehi, who heads clinical trials for COVIran Barekat, said the results of immunogenicity tests on 35 people who volunteered to take part in the first phase of human trials of the vaccine were better than expected.
“Preliminary results show that about 90 percent of the people who received two doses of the vaccine exhibit evidence of immunity,” he told IRNA news agency, noting that more testing is needed for more precise results.
Coviran Barekat was named after the pharmaceutical group that developed it.
Last month, the head of the production team of the Iranian coronavirus vaccine at the Headquarters for Executing the Order of Imam Khomeini said Coviran Barekat also works against the variant of coronavirus that first emerged in the UK.
Iran launched human trials of the vaccine late December after successfully completing the initial steps, including tests on animals, and obtaining necessary approvals.
By early this month, all 56 volunteers, who were accepted for the first phase of the vaccine’s human trials, had received both doses.
According to Salehi, the second phase of human trials is expected to start before the end of the current Persian calendar year on March 20 and last through May.
“Most probably the second and third phases will be merged together and preliminary reports will be submitted to the Food and Drug Administration half-way through this stage.”
Iranian scientists have been working on developing another domestic vaccine against the coronavirus, which is also in the human trial phase.
The second COVID-19 vaccine is a product of the Razi Vaccine and Serum Research Institute. Razi COV-Pars — an mRNA recombinant vaccine — is administered via injection and inhalation.
In parallel with efforts at developing homemade vaccines, Iran officially began the nationwide vaccination campaign against the COVID-19 with the Russian Sputnik V vaccine earlier this month, delivering jabs to frontline health workers in the first phase.
Your Comment